Another Way to Calculate Risk in Cystic Fibrosis Lung Transplantation Patients
Researchers have developed a new tool to calculate the risk of poor outcomes both post-transplant and during the waiting period.
Researchers have developed a new tool to calculate the risk of poor outcomes both post-transplant and during the waiting period.
AerosoLess Medical recently released the SafetyNebTM, an aerosol delivery device fitted with water-resistant viral filters.
As the number of chronic lung patients continues to grow, today’s aerosol therapy products are providing high-quality, cost-efficient medication delivery.